Cargando…
Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?
SIMPLE SUMMARY: For the last decade, the most successful approach for treating cancer has been the use of monoclonal antibodies to immune checkpoint inhibitors (ICI), also known as immune checkpoint blockers (ICB). Unfortunately, many cancers do not respond to these treatments. “Hot” tumors are thos...
Autor principal: | Karin, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699256/ https://www.ncbi.nlm.nih.gov/pubmed/34944943 http://dx.doi.org/10.3390/cancers13246317 |
Ejemplares similares
-
Turning ‘Cold’ tumors ‘Hot’: immunotherapies in sarcoma
por: Rytlewski, Jeff, et al.
Publicado: (2021) -
Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers
por: Sevenich, Lisa
Publicado: (2019) -
Turning cold tumors into hot tumors by improving T-cell infiltration
por: Liu, Yuan-Tong, et al.
Publicado: (2021) -
Nanoparticle-Based Therapies for Turning Cold Tumors Hot: How to Treat an Immunosuppressive Tumor Microenvironment
por: Giustarini, Giulio, et al.
Publicado: (2021) -
Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors
por: Kang, Byeong Hoon, et al.
Publicado: (2022)